QuidelOrtho Corporation QDEL
10.94
0.25
2.34%
as of 25 Sep
- Market cap
- $733.1M
- P/E
- 0.0×
Follow QDEL
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.74 | 0.71 | 0.42 | 0.45 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(44.01) | 14.68 | (33.96) | (10.82) | |
P/B ratio |
0.98 | 1.01 | 0.61 | 0.67 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.68 | 1.62 | 1.38 | 1.48 | |
EV/EBITDA |
17.23 | 19.76 | 22.24 | 11.79 | |
EV/Operating CF |
123.34 | 41.98 | 555.78 | (69.31) | |
EV/FCF |
(31.64) | (52.95) | (22.95) | (18.73) | |
Quick Ratio |
0.63 | 0.61 | 0.52 | 0.48 | |
Current Ratio |
1.78 | 1.50 | 1.43 | 1.39 | |
Net Debt/EBITDA |
26.43 | 53.69 | 31.41 | 24.69 | |
Debt/Assets |
46.85% | 45.94% | 47.76% | 50.59% | |
Debt/Equity |
1.31 | 1.38 | 1.45 | 1.63 | |
Asset Turnover |
0.44 | 0.45 | 0.44 | 0.44 | |
Operating CF/Net income |
0.06 | (1.01) | 0.36 | 1.19 | |
Capex/Depreciation |
(0.06) | (0.40) | (0.30) | (0.19) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
5.93% | 6.33% | 7.24% | 7.72% | |
Selling, General and Administrative Expense of Revenue |
26.70% | 26.87% | 32.16% | 30.07% | |
Intangible Assets out of Total Assets |
0.46 | 0.44 | 0.45 | 0.47 | |
Share Based Compensation of Revenue |
1.53% | 1.49% | 1.73% | 1.90% | |
Graham Net Nets |
(1.13) | (1.24) | (2.14) | (2.14) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(57.79%) | (58.33%) | (108.46%) | (87.96%) | |
Free Cash Flow Yield |
(7.20%) | (4.31%) | (14.26%) | (17.68%) | |
Revenue per Share |
10.29 | 10.67 | 9.09 | 9.24 | |
Operating CF per Share |
(0.67) | 1.95 | (0.48) | (1.62) | |
Capex per Share |
(0.72) | (0.67) | (0.50) | (0.37) | |
Free Cash Flow per Share |
(1.39) | 1.28 | (0.98) | (1.99) | |
Cash per Share |
1.44 | 2.50 | 2.06 | 1.81 | |
Shareholders Equity per Share |
29.95 | 28.33 | 27.15 | 25.99 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
29.95 | 28.33 | 27.15 | 25.99 | |
Free Cash Flow |
(94.70) | 86.60 | (67.00) | (136.10) | |
Working Capital |
598.80 | 481.20 | 414.60 | 383.20 | |
Capital Expenditures |
(49.20) | (45.30) | (34.00) | (25.50) | |
Net Current Asset Value |
(2,272.00) | (2,401.50) | (2,400.30) | (2,563.80) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.07 | 0.06 | 0.05 | 0.04 | |
Net Profit Margin |
(104.73%) | (18.06%) | (14.81%) | (14.72%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
340.70 | 349.70 | 322.95 | 313.50 | |
Average Payables |
230.45 | 262.70 | 237.20 | 227.65 | |
Average Inventory |
595.40 | 555.65 | 587.35 | 598.80 | |
Average Assets |
6,238.10 | 6,096.45 | 6,045.15 | 6,047.20 | |
Average Common Equity |
2,611.55 | 2,452.50 | 2,424.30 | 2,283.80 |
Columns are period end dates